다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
DiaMedica Therapeutics Inc (DMAC)
DiaMedica Therapeutics Inc (DMAC) 뉴스

DMAC

DiaMedica Therapeutics (DMAC)

DiaMedica Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DMAC

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/02	21:55	Business Wire	DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/04/18	05:08	Business Wire	DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/03/20	05:15	Business Wire	DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/01/30	06:13	Business Wire	DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/01/24	06:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/01/24	06:12	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/01/22	22:23	Business Wire	DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/01/03	07:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/01/03	06:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/01/03	06:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2024/01/03	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/11/17	06:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/11/14	06:55	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/11/14	06:52	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/11/14	06:28	Business Wire	DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/11/09	22:25	Business Wire	DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/11/06	22:23	Business Wire	DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/09/12	21:13	Business Wire	DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/09/06	21:35	Business Wire	DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/09/06	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/08/15	05:29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/08/15	05:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/08/15	05:13	Business Wire	DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/08/08	21:32	Business Wire	DiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/07/18	21:30	Business Wire	DiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/07/11	05:16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/07/10	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/07/01	05:16	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/06/28	05:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DMAC	DiaMedica Therapeutics Inc
2023/06/28	05:11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:DMAC	DiaMedica Therapeutics Inc

검색 관련기사 보기:NASDAQ:DMAC

1 2 3 4 5 6 7 8 9 10 다음 >>

BNP Paribas (QX)

American Express

Verizon Communications

US Dollar vs Euro

JP Morgan Chase

Gold vs US Dollar

Deutsche Telekom (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관